Pharma Journalist -

Neurimmune announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceutical Co., Ltd. In November 2017, the parties entered into a…
Read More...

Lonza announces the addition of two new Ibex Solutions offerings to Lonza's 100,000 m2 (1.1 million ft2) biopark in Visp (CH). In July 2017 Ibex Dedicate, a modular, technology-agnostic…
Read More...

Thermo Fisher Scientific announced its intent to open multiple Global Customer Solution Centers. The new Global Customer Solution Centers will focus on meeting and exceeding the demands…
Read More...

Emergex Vaccines Holding Limited announces that it has signed a Memorandum of Understanding (MoU) with Brazil-based Oswaldo Cruz Foundation ‘Fiocruz’ for the development of viral…
Read More...

Cardurion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) for CRD-733, a Phosphodiesterase-9…
Read More...

Aphena Pharma Solutions Inc. has expanded its DEA operations and storage in both its Maryland and Tennessee manufacturing locations. Aphena's liquid and semisolids division in Easton,…
Read More...

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer,…
Read More...

Zosano Pharma Corporation announced the release of three registration batches of M207, the Company’s lead development candidate. The registration batches will be used to support…
Read More...

Molecular Templates announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of CD38-targeted engineered toxin bodies (ETBs) for the…
Read More...

Abzena has signed an antibody humanisation agreement with Tmunity Therapeutics (Tmunity), a clinical stage T cell therapy company and a leader in the development of new Chimeric Antigen…
Read More...